186 related articles for article (PubMed ID: 27066749)
41. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
Thomenius MJ; Totman J; Harvey D; Mitchell LH; Riera TV; Cosmopoulos K; Grassian AR; Klaus C; Foley M; Admirand EA; Jahic H; Majer C; Wigle T; Jacques SL; Gureasko J; Brach D; Lingaraj T; West K; Smith S; Rioux N; Waters NJ; Tang C; Raimondi A; Munchhof M; Mills JE; Ribich S; Porter Scott M; Kuntz KW; Janzen WP; Moyer M; Smith JJ; Chesworth R; Copeland RA; Boriack-Sjodin PA
PLoS One; 2018; 13(6):e0197372. PubMed ID: 29856759
[TBL] [Abstract][Full Text] [Related]
42. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
Liu F; Chen X; Allali-Hassani A; Quinn AM; Wasney GA; Dong A; Barsyte D; Kozieradzki I; Senisterra G; Chau I; Siarheyeva A; Kireev DB; Jadhav A; Herold JM; Frye SV; Arrowsmith CH; Brown PJ; Simeonov A; Vedadi M; Jin J
J Med Chem; 2009 Dec; 52(24):7950-3. PubMed ID: 19891491
[TBL] [Abstract][Full Text] [Related]
43. Identification of a peptide inhibitor for the histone methyltransferase WHSC1.
Morrison MJ; Boriack-Sjodin PA; Swinger KK; Wigle TJ; Sadalge D; Kuntz KW; Scott MP; Janzen WP; Chesworth R; Duncan KW; Harvey DM; Lampe JW; Mitchell LH; Copeland RA
PLoS One; 2018; 13(5):e0197082. PubMed ID: 29742153
[TBL] [Abstract][Full Text] [Related]
44. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.
Vieira FQ; Costa-Pinheiro P; Almeida-Rios D; Graça I; Monteiro-Reis S; Simões-Sousa S; Carneiro I; Sousa EJ; Godinho MI; Baltazar F; Henrique R; Jerónimo C
Oncotarget; 2015 May; 6(15):13644-57. PubMed ID: 25980436
[TBL] [Abstract][Full Text] [Related]
45. Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines.
Kondengaden SM; Luo LF; Huang K; Zhu M; Zang L; Bataba E; Wang R; Luo C; Wang B; Li KK; Wang PG
Eur J Med Chem; 2016 Oct; 122():382-393. PubMed ID: 27393948
[TBL] [Abstract][Full Text] [Related]
46. A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth.
Peserico A; Germani A; Sanese P; Barbosa AJ; Di Virgilio V; Fittipaldi R; Fabini E; Bertucci C; Varchi G; Moyer MP; Caretti G; Del Rio A; Simone C
J Cell Physiol; 2015 Oct; 230(10):2447-2460. PubMed ID: 25728514
[TBL] [Abstract][Full Text] [Related]
47. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
Luo XG; Zou JN; Wang SZ; Zhang TC; Xi T
IUBMB Life; 2010 Mar; 62(3):194-9. PubMed ID: 20039369
[TBL] [Abstract][Full Text] [Related]
48. Nucleosome Binding Alters the Substrate Bonding Environment of Histone H3 Lysine 36 Methyltransferase NSD2.
Poulin MB; Schneck JL; Matico RE; Hou W; McDevitt PJ; Holbert M; Schramm VL
J Am Chem Soc; 2016 Jun; 138(21):6699-702. PubMed ID: 27183271
[TBL] [Abstract][Full Text] [Related]
49. Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
Hamamoto R; Silva FP; Tsuge M; Nishidate T; Katagiri T; Nakamura Y; Furukawa Y
Cancer Sci; 2006 Feb; 97(2):113-8. PubMed ID: 16441421
[TBL] [Abstract][Full Text] [Related]
50. Discovery of tetrahydrofuranyl spirooxindole-based SMYD3 inhibitors against gastric cancer via inducing lethal autophagy.
Zhu HP; Chai J; Qin R; Leng HJ; Wen X; Peng C; He G; Han B
Eur J Med Chem; 2023 Jan; 246():115009. PubMed ID: 36527933
[TBL] [Abstract][Full Text] [Related]
51. Structural basis of substrate methylation and inhibition of SMYD2.
Ferguson AD; Larsen NA; Howard T; Pollard H; Green I; Grande C; Cheung T; Garcia-Arenas R; Cowen S; Wu J; Godin R; Chen H; Keen N
Structure; 2011 Sep; 19(9):1262-73. PubMed ID: 21782458
[TBL] [Abstract][Full Text] [Related]
52. Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
Cowen SD; Russell D; Dakin LA; Chen H; Larsen NA; Godin R; Throner S; Zheng X; Molina A; Wu J; Cheung T; Howard T; Garcia-Arenas R; Keen N; Pendleton CS; Pietenpol JA; Ferguson AD
J Med Chem; 2016 Dec; 59(24):11079-11097. PubMed ID: 28002961
[TBL] [Abstract][Full Text] [Related]
53. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.
Barsyte-Lovejoy D; Li F; Oudhoff MJ; Tatlock JH; Dong A; Zeng H; Wu H; Freeman SA; Schapira M; Senisterra GA; Kuznetsova E; Marcellus R; Allali-Hassani A; Kennedy S; Lambert JP; Couzens AL; Aman A; Gingras AC; Al-Awar R; Fish PV; Gerstenberger BS; Roberts L; Benn CL; Grimley RL; Braam MJ; Rossi FM; Sudol M; Brown PJ; Bunnage ME; Owen DR; Zaph C; Vedadi M; Arrowsmith CH
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12853-8. PubMed ID: 25136132
[TBL] [Abstract][Full Text] [Related]
54. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications.
Rubio-Tomás T
Mol Biol Rep; 2021 Nov; 48(11):7499-7508. PubMed ID: 34510321
[TBL] [Abstract][Full Text] [Related]
55. Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Woo J; Kim HY; Byun BJ; Chae CH; Lee JY; Ryu SY; Park WK; Cho H; Choi G
Bioorg Med Chem Lett; 2014 Jun; 24(11):2486-92. PubMed ID: 24767850
[TBL] [Abstract][Full Text] [Related]
56. Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors.
Jarrell DK; Hassell KN; Alshiraihi I; Crans DC; Brown MA
Diseases; 2021 Dec; 10(1):. PubMed ID: 35076487
[TBL] [Abstract][Full Text] [Related]
57. Structure-Activity Relationship Studies on (R)-PFI-2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7.
Lenstra DC; Damen E; Leenders RGG; Blaauw RH; Rutjes FPJT; Wegert A; Mecinović J
ChemMedChem; 2018 Jul; 13(14):1405-1413. PubMed ID: 29869845
[TBL] [Abstract][Full Text] [Related]
58. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
59. SMYD3-NY, a novel SMYD3 mRNA transcript variant, may have a role in human spermatogenesis.
Zhou Z; Ren X; Huang X; Lu L; Xu M; Yin L; Li J; Sha J
Ann Clin Lab Sci; 2005; 35(3):270-7. PubMed ID: 16081583
[TBL] [Abstract][Full Text] [Related]
60. Detecting S-adenosyl-L-methionine-induced conformational change of a histone methyltransferase using a homogeneous time-resolved fluorescence-based binding assay.
Lin Y; Fan H; Frederiksen M; Zhao K; Jiang L; Wang Z; Zhou S; Guo W; Gao J; Li S; Harrington E; Meier P; Scheufler C; Xu YC; Atadja P; Lu C; Li E; Gu XJ
Anal Biochem; 2012 Apr; 423(1):171-7. PubMed ID: 22342622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]